We are driving the next generation of discoveries to address critical cancer challenges and accelerate the translation of scientific evidence into patient benefit.
Fostering an outstanding cancer care workforce to help maintain and enhance world-leading patient outcomes through online learning, courses and events.
Anti-cancer treatment venetoclax listed on Australian PBS
Underpinned by three decades of scientific determination and collaboration
A new targeted treatment option for patients with Chronic Lymphocytic Leukaemia (CLL) will be available from 1 March 2019 through the Australian Pharmaceutical Benefits Scheme (PBS).
